Literature DB >> 3558660

Hospital routine analysis of penicillins, third-generation cephalosporins and aztreonam by conventional and high-speed high-performance liquid chromatography.

F Jehl, P Birckel, H Monteil.   

Abstract

A high-performance liquid chromatographic procedure for the measurement of fifteen beta-lactam antibiotics in body fluids is described, with special reference to high-speed techniques. The procedure involves a unique sample preparation before analysis for all the following fifteen compounds: benzylpenicillin, ampicillin, cloxacillin, ticarcillin, mezlocillin, azlocillin, piperacillin, cefotaxime and its desacetyl metabolite, cefsulodin, cefoperazone, cefmenoxime, ceftazidime, ceftriaxone and the monobactam aztreonam; thus all biological samples arriving at the laboratory can be treated in batch. Of these fifteen antibiotics, eleven can be chromatographed with the same type of mobile phase, which consists of a mixture of ammonium acetate and acetonitrile in various ratios. Three others need ionpairing chromatography because of their polarity, and ticarcillin requires citric acid. High-speed high-performance liquid chromatography seems to be particularly suitable for the routine analysis of beta-lactam antibiotics because columns equilibrate more rapidly, retention times are much shorter, detection limits are lower and the longer lifetime of columns reduces analysis costs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558660     DOI: 10.1016/0378-4347(87)80218-9

Source DB:  PubMed          Journal:  J Chromatogr


  14 in total

1.  Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring.

Authors:  Marie-Clémence Verdier; Olivier Tribut; Pierre Tattevin; Yves Le Tulzo; Christian Michelet; Danièle Bentué-Ferrer
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  High hepatic excretion in humans of cefpiramide, a new cephalosporin.

Authors:  J M Brogard; F Jehl; M Adloff; J F Blickle; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.

Authors:  J Chesa-Jiménez; J E Peris; F Torres-Molina; L Granero
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

4.  Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport?

Authors:  Miki Susanto; Leslie Z Benet
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

5.  Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.

Authors:  I R Friedland; E Sultan; K H Lehr; B Lenfant
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

6.  Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.

Authors:  Alexander A Vinks; Ronald N van Rossem; Ron A A Mathôt; Harry G M Heijerman; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.

Authors:  H Mentec; J M Vallois; A Bure; A Saleh-Mghir; F Jehl; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

9.  Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis.

Authors:  L Granero; M Santiago; J Cano; A Machado; J E Peris
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patients.

Authors:  F Jehl; J D Peter; A Picard; J P Dupeyron; J Marescaux; A Sibilly; H Monteil
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.